Grant: Discovery Grants Program - Individual
Queen's University
$43,500.00
Nanoencapsulation of therapeutic peptides in smart environmentally responsive biopolymers
EF 2007-08
Résumé
My research is directed toward the immobilization via entrapment of biologicals, including living cells, enzymes and other biologically active materials such as DNA and therapeutic peptides. The intent is to package the biological material, typically within small spherical particles or gels, termed microspheres or microcapsules. The particles provide a protective environment, enabling retention, stabilization, and/or controlled delivery for therapeutic and other applications. Microencapsulation protocols are designed to form micron-sized (approximately 50 microns to 1 mm diameter) coated or uncoated particles and gels, containing the bioactive material. The intent of the research outlined in this proposal is to extend the particle size into the nano-scale, from 150 nm to a few microns in diameter. Therapeutic peptides will be examined for nanoencapsulation and controlled delivery including insulin and human vascular endothelial growth factor. The nanoparticles will be designed to be environmentally responsive, "smart" gels in that they will swell or contract in response to environmental triggers such as a change in pH. This responsive behavior will be important for the loading and retention of large and small proteins/peptides respectively, and for controlled or triggered release of the peptide, depending on the intended therapeutic application. This research provides a wonderful opportunity for the training of highly qualified personnel, since it is multi-disciplinary, spanning the fields of chemical, biochemical and biomedical engineering, with a strong emphasis on biopolymeric materials, biotechnology and nanotechnology, supported through experimental methods and instrumentation. The fields of pharmaceuticals, biotech products, biomedical devices, advanced materials, nanoproducts and nanotechnologies are growing rapidly and are identified as strategic priorities in the most recent reallocation exercise. Oral administration of a protein-based drug such as insulin would be an important breakthrough, and will depend on research, training and expertise in all of these fields.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
204794-2006
Name nom
Neufeld, Ronald
Department département
Chemical Engineering
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
43500
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
2
Nb partie
5
Application title
Nanoencapsulation of therapeutic peptides in smart environmentally responsive biopolymers
Keyword
NA
Application summary
My research is directed toward the immobilization via entrapment of biologicals, including living cells, enzymes and other biologically active materials such as DNA and therapeutic peptides. The intent is to package the biological material, typically within small spherical particles or gels, termed microspheres or microcapsules. The particles provide a protective environment, enabling retention, stabilization, and/or controlled delivery for therapeutic and other applications. Microencapsulation protocols are designed to form micron-sized (approximately 50 microns to 1 mm diameter) coated or uncoated particles and gels, containing the bioactive material. The intent of the research outlined in this proposal is to extend the particle size into the nano-scale, from 150 nm to a few microns in diameter. Therapeutic peptides will be examined for nanoencapsulation and controlled delivery including insulin and human vascular endothelial growth factor. The nanoparticles will be designed to be environmentally responsive, "smart" gels in that they will swell or contract in response to environmental triggers such as a change in pH. This responsive behavior will be important for the loading and retention of large and small proteins/peptides respectively, and for controlled or triggered release of the peptide, depending on the intended therapeutic application. This research provides a wonderful opportunity for the training of highly qualified personnel, since it is multi-disciplinary, spanning the fields of chemical, biochemical and biomedical engineering, with a strong emphasis on biopolymeric materials, biotechnology and nanotechnology, supported through experimental methods and instrumentation. The fields of pharmaceuticals, biotech products, biomedical devices, advanced materials, nanoproducts and nanotechnologies are growing rapidly and are identified as strategic priorities in the most recent reallocation exercise. Oral administration of a protein-based drug such as insulin would be an important breakthrough, and will depend on research, training and expertise in all of these fields.